Literature DB >> 25592583

Identification of gene-gene and gene-environment interactions within the fibrinogen gene cluster for fibrinogen levels in three ethnically diverse populations.

Janina M Jeff1, Kristin Brown-Gentry, Dana C Crawford.   

Abstract

Elevated levels of plasma fibrinogen are associated with clot formation in the absence of inflammation or injury and is a biomarker for arterial clotting, the leading cause of cardiovascular disease. Fibrinogen levels are heritable with >50% attributed to genetic factors, however little is known about possible genetic modifiers that might explain the missing heritability. The fibrinogen gene cluster is comprised of three genes (FGA, FGB, and FGG) that make up the fibrinogen polypeptide essential for fibrinogen production in the blood. Given the known interaction with these genes, we tested 25 variants in the fibrinogen gene cluster for gene x gene and gene x environment interactions in 620 non-Hispanic blacks, 1,385 non-Hispanic whites, and 664 Mexican Americans from a cross-sectional dataset enriched with environmental data, the Third National Health and Nutrition Examination Survey (NHANES III). Using a multiplicative approach, we added cross product terms (gene x gene or gene x environment) to a linear regression model and declared significance at p < 0.05. We identified 19 unique gene x gene and 13 unique gene x environment interactions that impact fibrinogen levels in at least one population at p < 0.05. Over 90% of the gene x gene interactions identified include a variant in the rate-limiting gene, FGB that is essential for the formation of the fibrinogen polypeptide. We also detected gene x environment interactions with fibrinogen variants and sex, smoking, and body mass index. These findings highlight the potential for the discovery of genetic modifiers for complex phenotypes in multiple populations and give a better understanding of the interaction between genes and/or the environment for fibrinogen levels. The need for more powerful and robust methods to identify genetic modifiers is still warranted.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25592583      PMCID: PMC4357227     

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  15 in total

1.  Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.

Authors:  Bernard C B Lim; Robert A S Ariëns; Angela M Carter; John W Weisel; Peter J Grant
Journal:  Lancet       Date:  2003-04-26       Impact factor: 79.321

2.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

3.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

4.  Fibrinogen assembly and secretion. Role of intrachain disulfide loops.

Authors:  J Z Zhang; C Redman
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

5.  Genetic variation in the fibrinogen gene cluster.

Authors:  Moniek P M de Maat
Journal:  Thromb Haemost       Date:  2005-03       Impact factor: 5.249

Review 6.  Fibrinogen structure and fibrin clot assembly.

Authors:  M W Mosesson
Journal:  Semin Thromb Hemost       Date:  1998       Impact factor: 4.180

Review 7.  Effects of diet, drugs, and genes on plasma fibrinogen levels.

Authors:  M P de Maat
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

8.  Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen.

Authors:  J Z Zhang; C M Redman
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

9.  Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure.

Authors:  J P Collet; J Soria; M Mirshahi; M Hirsch; F B Dagonnet; J Caen; C Soria
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

Review 10.  Genetic determinants of arterial thrombosis.

Authors:  Barbara Voetsch; Joseph Loscalzo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-11-13       Impact factor: 8.311

View more
  4 in total

1.  Leveraging Epidemiologic and Clinical Collections for Genomic Studies of Complex Traits.

Authors:  Dana C Crawford; Robert Goodloe; Eric Farber-Eger; Jonathan Boston; Sarah A Pendergrass; Jonathan L Haines; Marylyn D Ritchie; William S Bush
Journal:  Hum Hered       Date:  2015-07-28       Impact factor: 0.444

2.  Population Stratification in the Context of Diverse Epidemiologic Surveys Sans Genome-Wide Data.

Authors:  Matthew T Oetjens; Kristin Brown-Gentry; Robert Goodloe; Holli H Dilks; Dana C Crawford
Journal:  Front Genet       Date:  2016-05-06       Impact factor: 4.599

3.  Cryptic relatedness in epidemiologic collections accessed for genetic association studies: experiences from the Epidemiologic Architecture for Genes Linked to Environment (EAGLE) study and the National Health and Nutrition Examination Surveys (NHANES).

Authors:  Jennifer Malinowski; Robert Goodloe; Kristin Brown-Gentry; Dana C Crawford
Journal:  Front Genet       Date:  2015-10-26       Impact factor: 4.599

4.  Molecular assessment of some cardiovascular genetic risk factors among Iraqi patients with ischemic heart diseases.

Authors:  Wisam Jasim Mohammed; Bassam Musa Sadik Al-Musawi; Christian Oberkanins; Helene Pühringer
Journal:  Int J Health Sci (Qassim)       Date:  2018 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.